Lumira Ventures

Lumira Ventures is a life sciences venture capital firm, investing in companies developing therapeutic products and medical devices. The firm supports innovations across the full development continuum for therapeutics, and late-stage clinical to revenue-generating devices. Its strategy targets diverse therapeutic areas with significant unmet needs, advancing critical healthcare solutions.

The firm’s current identity began in 2007, following a management buyout of MDS Capital by its partners, rebranding as Lumira Ventures. This established independence, focusing specialized capital and deep industry expertise on life sciences. The core insight involved fostering advancements for critical global health challenges.

Lumira Ventures supports portfolio companies across biotech, medtech, and healthcare with capital and strategic guidance. Its vision enhances patient outcomes by developing and commercializing transformative therapeutic solutions. The firm aims to overcome treatment barriers, promote inclusivity, improve clinical results, and reduce healthcare costs.